InMode Ltd
$ 13.53
-1.17%
10 Apr - close price
- Market Cap 944,345,000 USD
- Current Price $ 13.53
- High / Low $ 13.78 / 13.35
- Stock P/E 6.28
- Book Value 9.94
- EPS 2.38
- Next Earning Report 2026-04-27
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA 0.09 %
- ROE 0.26 %
- 52 Week High 19.85
- 52 Week Low 13.14
About
InMode Ltd. designs, develops, manufactures and markets minimally invasive aesthetic medical products based on its proprietary RF-assisted lipolysis and deep subdermal fractional RF technologies. The company is headquartered in Yokneam, Israel.
Analyst Target Price
$16.25
Quarterly Earnings
| Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-02-10 | 2025-11-05 | 2025-07-30 | 2025-04-28 | 2025-02-04 | 2024-10-30 | 2024-08-01 | 2024-05-02 | 2024-02-13 | 2023-11-02 | 2023-07-27 | 2023-05-02 |
| Reported EPS | 0.46 | 0.38 | 0.47 | 0.31 | 1.14 | 0.7 | 0.34 | 0.32 | 0.71 | 0.61 | 0.72 | 0.52 |
| Estimated EPS | 0.42 | 0.35 | 0.41 | 0.35 | 0.47 | 0.61 | 0.38 | 0.41 | 0.67 | 0.63 | 0.66 | 0.48 |
| Surprise | 0.04 | 0.03 | 0.06 | -0.04 | 0.67 | 0.09 | -0.04 | -0.09 | 0.04 | -0.02 | 0.06 | 0.04 |
| Surprise Percentage | 9.5238% | 8.5714% | 14.6341% | -11.4286% | 142.5532% | 14.7541% | -10.5263% | -21.9512% | 5.9701% | -3.1746% | 9.0909% | 8.3333% |
Next Quarterly Earnings
| Mar 2026 | |
|---|---|
| Reported Date | 2026-04-27 |
| Fiscal Date Ending | 2026-03-31 |
| Estimated EPS | |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: INMD
2026-04-09 20:40:17
Michael Kreindel, CTO and director of InMode Ltd., has disclosed a 5.11% stake in the company via a Schedule 13D filing on April 9, 2026. His increased ownership is attributed to InMode's share repurchases, not new share purchases, and he holds the shares for investment purposes, engaging with the company's board on operations and governance. Kreindel, co-founder of InMode, maintains a long-term investment view and has made no trades in the last 60 days.
2026-04-09 20:40:17
Moshe Mizrahy, an insider at InMode Ltd. (NASDAQ: INMD), has increased his beneficial ownership stake to 7.06% by acquiring 800,000 shares for approximately US$10.7 million using personal funds. This increase was also significantly influenced by InMode's repurchase of about 2.9 million shares, which reduced the total outstanding shares. The updated Schedule 13D/A filing details this material change in ownership, highlighting Mizrahy's increased stake in the company.
2026-04-09 19:40:17
InMode Ltd. (INMD) CTO Michael Kreindel has reported a 5.11% beneficial ownership stake in the company through a Schedule 13D filing. This increase above the 5% threshold was due to InMode's share repurchase program reducing outstanding shares, not new acquisitions by Kreindel. All 3,114,762 shares were acquired before InMode's IPO in 2019 for investment purposes, and he has not traded shares in the last 60 days.
2026-04-08 15:39:05
InMode (INMD) expects its first-quarter sales to be below previous estimates. The company attributed this to a challenging macroeconomic environment impacting capital equipment purchases. Despite the sales revision, InMode reiterated its full-year revenue outlook, suggesting that the Q1 underperformance might be a temporary hiccup.
2026-04-08 08:13:24
InMode (INMD) announced that it expects its first-quarter sales to be below analysts' average estimates. The medical technology company, known for its minimally invasive aesthetic solutions, anticipates reporting Q1 sales in the range of $98 million to $98.3 million. This projection falls short of the market consensus Zacks estimate of $105.8 million, indicating a potential impact on its stock performance.
2026-04-02 11:39:03
This page provides access to Inmode Ltd. (INMD) SEC filings, including annual reports (20-F), quarterly reports (6-K), and other material event disclosures. It highlights key financial data, management commentary, and legal proceedings, with AI-powered summaries to aid investor analysis. Recent filings discuss 2025 risks, Q4 and full-year 2025 financial results showing a revenue decline, and the evaluation of a 51% acquisition proposal from Steel Partners, alongside updates on a securities class action lawsuit.
